Summit Therapeutics Inc vs Vertiv Holdings Co — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Vertiv Holdings Co trades at $306.03 (market cap $112.03B). The key difference: Vertiv Holdings Co is far larger — about 10.7× Summit Therapeutics Inc's market cap, and Vertiv Holdings Co pays a 0.09% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | VRT | |
|---|---|---|
Market Cap | $10.48B | $112.03B |
Sector | Health | Technology |
52-Week High | $29.32 | $376.23 |
52-Week Low | $13.05 | $121.82 |
Enterprise Value | $9.90B | $112.80B |
Dividend Yield | — | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →